✦ LIBER ✦

Cytogenetic heterogeneity and progression of esophageal squamous cell carcinoma

✍ Scribed by Hisanori Shiomi; Hiroyuki Sugihara; Sumihiro Kamitani; Tomoki Tokugawa; Yasuhiro Tsubosa; Katsuji Okada; Hiroki Tamura; Tohru Tani; Masashi Kodama; Takanori Hattori

Book ID: 114135661
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 451 KB
Volume: 147
Category: Article
ISSN: 0165-4608
DOI: 10.1016/s0165-4608(03)00159-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Heterogeneity ofp53Mutational Status in

Heterogeneity ofp53Mutational Status in Esophageal Squamous Cell Carcinoma

✍ Kuwabara, Shirou ;Ajioka, Yoichi ;Watanabe, Hidenobu ;Hitomi, Jiro ;Nishikura, K 📂 Article 📅 1998 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 429 KB

Cytogenetic studies of primary cultures

Cytogenetic studies of primary cultures of esophageal squamous cell carcinoma

✍ Lynne S. Rosenblum-Vos; Stephen J. Meltzer; Julie Leana-Cox; Stuart Schwartz 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Intratumoral heterogeneity in DNA ploidy

Intratumoral heterogeneity in DNA ploidy of esophageal squamous cell carcinomas

✍ Kohsuke Sasaki; Tomoyuki Murakami; Takuo Murakami; Masayuki Nakamura 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 2 views

Correlation between RhoA overexpression

Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma

✍ A. Faried; M. Nakajima; M. Sohda; T. Miyazaki; H. Kato; H. Kuwano 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Chemoprevention of esophageal squamous c

Chemoprevention of esophageal squamous cell carcinoma

✍ Gary D. Stoner; Li-Shu Wang; Tong Chen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 833 KB

Positive correlation between P27Kip1 exp

Positive correlation between P27Kip1 expression and progression of human esophageal squamous cell carcinoma

✍ Takashi Anayama; Mutsuo Furihata; Tadanori Ishikawa; Yuji Ohtsuki; Shohei Ogoshi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 588 KB

p27 Kip1 , one of the cyclin-dependent kinase (CDK) inhibitors (CDKIs), blocks progression from G 1 to S phase by binding cyclin D1-CDK4 and/or cyclin E-CDK2 and inhibiting their activities. Reflecting the function of p27 as a CDKI in vitro, a reduced expression of protein p27 has recently been repo